Lipoprotein(a): Why This Test Matters and What a High Result Means

TL;DR: Lipoprotein(a), or Lp(a), is a genetically determined particle that raises cardiovascular risk independently of LDL cholesterol. It's set almost entirely by genetics, has a half-life of only three to four days but stays relatively stable across your lifetime, and isn't included in most standard cholesterol panels. According to European Atherosclerosis Society (EAS) consensus guidance, a result above 50 mg/dL is considered high risk, and treatment targets bringing it below that threshold when possible. Most people have never had it tested, since it's usually only ordered on request or with specific risk factors.

What Is Lipoprotein(a) and How Is It Different From LDL?

Lipoprotein(a) is an LDL-like particle with an extra protein, apolipoprotein(a), attached. That extra component makes it more likely to promote both plaque buildup in arteries and blood clotting (by interfering with the body's natural clot-dissolving process), which is why elevated Lp(a) is linked to earlier heart attacks and strokes, independent of your standard LDL number.

The key difference: LDL levels are influenced by diet, exercise, weight, and medication. Lp(a) levels are almost entirely genetic, set early in life by the LPA gene, and are only slightly affected by diet, exercise, or other lifestyle factors. This means someone with an excellent diet and exercise routine can still carry elevated cardiovascular risk if their Lp(a) is high.

What Counts as a High Lp(a) Result?

According to established clinical risk categories:

• Desirable: below 14 mg/dL (under 35 nmol/L)
• Borderline risk: 14–30 mg/dL (35–75 nmol/L)
• High risk: 31–50 mg/dL (75–125 nmol/L)
• Very high risk: above 50 mg/dL (over 125 nmol/L)

The European Atherosclerosis Society's guidance is to treat toward a target below 50 mg/dL when Lp(a) is elevated, alongside optimal management of other risk factors like LDL and blood pressure.

Who Should Get Tested for Lipoprotein(a)?

European Atherosclerosis Society consensus guidance recommends Lp(a) testing for anyone with:

• Premature cardiovascular disease
• Familial hypercholesterolemia
• A family history of premature cardiovascular disease
• A family history of elevated Lp(a)
• Recurrent cardiovascular disease despite statin treatment
• An elevated calculated 10-year cardiovascular risk score

The American Academy of Pediatrics also recommends that children be screened for hyperlipidemia between ages 9 and 11, with Lp(a) specifically considered when there's a family history of early heart disease.

Lp(a) vs. LDL vs. ApoB: What Each Marker Tells You

Marker	What It Reflects	Changes With Lifestyle?	Genetic Component
LDL cholesterol	Cholesterol carried by LDL particles	Yes, significantly	Moderate
ApoB	Total count of atherogenic particles	Yes, moderately	Moderate
Lipoprotein(a)	Genetically-driven particle with clotting risk	Only slightly	High (largely inherited)

What Does a High Lp(a) Result Actually Mean for Treatment?

A high result means your baseline cardiovascular risk is higher than your LDL number alone suggests. Because Lp(a) responds only modestly to most standard interventions, management typically shifts to being more aggressive with the risk factors that can be controlled: lowering LDL further than the general guideline, managing blood pressure tightly, and addressing other modifiable risks. Niacin can lower Lp(a) by an estimated 20 to 30%, and some statins (atorvastatin, in particular) have shown modest effects in meta-analyses, though results have been mixed across trials. Several targeted therapies, including antisense and siRNA drugs (such as pelacarsen and olpasiran), are in Phase 2 and Phase 3 trials but are not yet approved as standard treatment.

Should Family Members Get Tested Too?

Because Lp(a) is inherited, a high result in one person often means first-degree relatives (parents, siblings, children) are worth testing as well. A single result can prompt a useful screening conversation across a family, potentially catching elevated risk in relatives years before symptoms would appear.

Related AION Resources

AION's cardiovascular and biological age diagnostics pathway interprets Lp(a) alongside your full lipid and particle-count picture, not in isolation. Our companion guide on ApoB testing covers the other advanced marker increasingly used alongside LDL. For the evidence behind advanced cardiovascular risk assessment, see our review of arterial stiffness and pulse wave velocity.

FAQ

What Lp(a) level is considered high risk? According to established risk categories, 31–50 mg/dL is considered high risk, and above 50 mg/dL is very high risk. Treatment guidance targets bringing elevated levels below 50 mg/dL.

Can diet or exercise lower Lipoprotein(a)? Only slightly. Lp(a) is almost entirely determined by genetics and does not respond to lifestyle changes the way LDL cholesterol does.

Why isn't Lp(a) tested in a standard cholesterol panel? Standard panels typically measure total cholesterol, LDL, HDL, and triglycerides. Lp(a) requires a separate, specific test that isn't automatically included.

Who should be screened for Lp(a) according to clinical guidance? The European Atherosclerosis Society recommends testing for people with premature cardiovascular disease, familial hypercholesterolemia, a family history of early heart disease or elevated Lp(a), recurrent cardiovascular disease despite statin treatment, or elevated calculated risk scores.

Should my family get tested if my Lp(a) is high? Yes. Since Lp(a) is inherited, first-degree relatives are often worth testing as well.

Is there medication specifically for high Lp(a)? Niacin can lower Lp(a) by an estimated 20 to 30%, though its cardiovascular benefit is debated. Several targeted drugs are in late-stage clinical trials but are not yet approved as standard treatment.